Market Overview

Live Nation Entertainment Acquires Voodoo Music & Arts Experience

Share:

;Live Nation Entertainment (NYSE: LYV) has acquired Voodoo Music & Arts Experience, New Orleans' critically-acclaimed music festival. The annual music and art celebration has hosted a wide range of artists from Metallica and Red Hot Chili Peppers to Neil Young and Skrillex.

This year Voodoo will celebrate its 15th anniversary with Kid Rock, Pearl Jam, Nine Inch Nails, Calvin Harris, Paramore, Bassnectar and many others. For the complete line up, please visit http://lineup.worshipthemusic.com. 

"I am grateful for the opportunity to join the Live Nation team," said Stephen Rehage. "Our outlooks on the festival market are aligned and we look to grow the Live Nation festival roster over the coming years."

"Stephen has built a remarkable brand and I'm looking forward to working with him to continue to enhance Voodoo and the other Live Nation festivals in the U.S.," said Bob Roux, co-president of North America concerts, Live Nation Entertainment.

The 2013 Voodoo Music & Arts Experience is scheduled for Nov. 1 – 3 in New Orleans. For more information about Voodoo: http://www.worshipthemusic.com.

See full press release

Posted-In: M&A News Guidance Offerings Contracts Asset Sales Management Global

 

Related Articles (LYV)

View Comments and Join the Discussion!
Need corporate guidance data?
Click here to see licensing options.
Fastest Market News Application
You'll Hear It First On Pro
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

Viad Corp Declares Special Cash Dividend Of $2.50/Share

Sorrento Therapeutics Prices 4.15M Share Offering at $7,25/Share